Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
Works of Hemant S. Murthy being referenced
A phase 1 dose escalation and cohort expansion study of the safety and efficacy of allogeneic CRISPR-Cas9–engineered T cells (CTX110) in patients (Pts) with relapsed or refractory (R/R) B-cell malignancies (CARBON).
2021
<p>Cytokine Release Syndrome: Current Perspectives</p>
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hemant S. Murthy | 322 | 212 | 77 | 134 | 99 | 677 | |
| Riad El Fakih | 202 | 260 | 101 | 82 | 75 | 617 | |
| Étienne Daguindau | 191 | 216 | 91 | 219 | 54 | 786 | |
| Farhad Khimani | 433 | 115 | 61 | 91 | 65 | 691 | |
| Mahmoud M. Kamel | 113 | 118 | 48 | 78 | 85 | 746 | |
| Mariusz Wysocki | 204 | 229 | 233 | 93 | 146 | 839 | |
| Manuel Guerreiro | 338 | 140 | 46 | 254 | 55 | 663 | |
| Sung Soo Yoon | 208 | 319 | 138 | 68 | 58 | 803 | |
| Piotr Rzepecki | 160 | 137 | 50 | 147 | 64 | 615 | |
| Drago Batinić | 122 | 252 | 73 | 181 | 72 | 842 | |
| J Ellegaard | 148 | 195 | 102 | 224 | 49 | 746 |
All Works
Login with ORCID to disown or claim papers
Loading papers...